الفهرس 
Clinical implications of dobutamine- atropine stressOnly 14 pages are availabe for public view
 |  | from | 115 |  |  |
| | | from | 115 | | |
Abstract
Dobutamine — atropine stress echocardiography has been shown to be highly feasible and safe and to provide useful diagnostic and prognostic information in patients with suspected or proved coronary artery disease, However, its safety and accuracy for detection of residual stenosis of the infarct related artery and multivessel disease early after acute myocardial infarction remain unclear. To document the safety of dobutamine atropine stress echocardiography within the first week after acute myocardial infarction and to investigate the accuracy of wall motion in the infarction zone for detection of residual stenosis of the infarct related artery and the accuracy of wall motion out side the infarction zone for multivessel disease, 35 patients (33 males and 2 females) with their Irst acute myocardial infarction were enrolled in this study.
Five patients were excluded, 2 due to patient refusal, 2 due to
poor echo window and one patient due to the presence of severe
myopathic changes.
Dobutamine — atropine stress echo was performed 7±2 days after infarction using multistage protocol, 5 10,20,30,40 ug.kg. mm with echo stage lasting 5 minutes. Intravenous atropine was used when required.